BioCentury
ARTICLE | Clinical News

Ecabet sodium: Preliminary Phase IIb data

June 4, 2007 7:00 AM UTC

Preliminary results from a double-blind, placebo-controlled, Phase IIb trial in 112 patients showed trends on 2 of 4 primary endpoints and statistical significance on a third. The company said the tri...